Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 May;21(5):1689-1690.
doi: 10.1111/ajt.16419. Epub 2020 Dec 22.

Does the definition of chronic active T cell-mediated rejection need revisiting?

Maarten Naesens  1   2 , Mark Haas  3 , Alexandre Loupy  4 , Candice Roufosse  5 , Michael Mengel  6
Affiliations
Free article
Comment

Does the definition of chronic active T cell-mediated rejection need revisiting?

Maarten Naesens et al. Am J Transplant. 2021 May.
Free article
No abstract available

Keywords: biopsy; classification systems: Banff classification; clinical research/practice; kidney transplantation/nephrology; pathology/histopathology; rejection: T cell mediated (TCMR); rejection: chronic.

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Haas M, Loupy A, Lefaucheur C, et al. The Banff 2017 Kidney Meeting Report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials. Am J Transplant. 2018;18(2):293-307.
    1. Nakagawa K, Tsuchimoto A, Ueki K, et al. Significance of revised criteria for chronic active T cell-mediated rejection in the 2017 Banff classification: surveillance by 1-year protocol biopsies for kidney transplantation. Am J Transplant. 2020. https://doi.org/10.1111/ajt.16093
    1. Matas AJ, Helgeson ES, Gaston R, et al. Inflammation in areas of fibrosis: the DeKAF prospective cohort. Am J Transplant. 2020;20(9):2509-2521.
    1. Helgeson ES, Mannon R, Grande J, et al. i-IFTA and chronic active T-cell mediated rejection: a tale of 2 (DeKAF) cohorts. Am J Transplant. 2020. https://doi.org/10.1111/ajt.16352
    1. Halloran PF, Matas A, Kasiske BL, Madill-Thomsen KS, Mackova M, Famulski KS. Molecular phenotype of kidney transplant indication biopsies with inflammation in scarred areas. Am J Transplant. 2019;19(5):1356-1370.